Analyst firms · UBS · CNC
UBS CNC price target and rating history
Centene Corporation (CNC) · Health Care
UBS rates Centene Corporation (CNC) Neutral with a $45 price target, as of its latest action on Jul 2, 2025. It has published 3 rating actions on CNC since June 2023, including 1 upgrade and 1 downgrade. Across 6 firms with a CNC price target in the last 12 months, the median target is $65.
- Current rating
- Neutral
- Price target
- $45
- Median target, all firms
- $65
- Actions on CNC
- 3
UBS price target on CNC
Every UBS rating on CNC
- Jul 2, 2025
- Dec 13, 2024
- Jun 20, 2023
How other firms rate CNC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Buy | $80 | Aug 11, 2026 |
| RBC Capital Markets | Sector Perform | $70 | Jun 23, 2026 |
| Deutsche Bank | Buy | $80 | May 20, 2026 |
| Cantor Fitzgerald | Overweight | $60 | Apr 29, 2026 |
| BofA Securities | Buy | $60 | Apr 29, 2026 |
| Barclays | Overweight | $54 | Jan 5, 2026 |
Questions about UBS and CNC
- What is UBS's price target for CNC?
- UBS's latest stated price target for Centene Corporation (CNC) is $45, from its action on Jul 2, 2025.
- What is UBS's rating on CNC?
- UBS rates CNC Neutral, a neutral rating, as of Jul 2, 2025.
- When did UBS last change its view on CNC?
- On Jul 2, 2025, UBS downgrades to Neutral from Buy, price target $45.
- How does UBS's CNC target compare with other analysts?
- Across 6 firms with a CNC price target in the last 12 months, the median target is $65.
More CNC rating histories
- Argus Research3
- Deutsche Bank3
- Cantor Fitzgerald3
- BofA Securities5
- Barclays5
- Wells Fargo5
- Morgan Stanley7
- Jefferies4
- Credit Suisse4
All UBS ratingsCNC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.